Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Targeting versus tinkering: Explaining why the clinic is frustrated with molecular mapping of disease mechanisms.

In English

Författare

Summary, in English

We argue that our common diseases should not necessarily be taken as a sign of physiological error. Regulatory networks developed by evolutionary forces to support reproductive fitness happen to include disease as a side-effect. For example, inflammatory and autoimmune diseases are secondary to a strong defence against infections. An evolutionary perspective can help us understand why many drugs targeted to single molecules or linear signaling pathways fail in clinical trials. We present the hypothesis that a tinkering research strategy, as compared with the prevailing reductionist approach, may be more likely to help us find the tools needed to interfere optimally with disease-generating networks. One application of the hypothesis can be to analyze how manipulation with diet and gut microbial flora influences multiple sclerosis patients, rather than to first map in detail the molecular disease mechanism and then develop targeting drugs.

Publiceringsår

2013

Språk

Engelska

Sidor

553-556

Publikation/Tidskrift/Serie

Medical Hypotheses

Volym

81

Issue

4

Dokumenttyp

Artikel i tidskrift

Förlag

Churchill Livingstone

Ämne

  • Microbiology in the medical area
  • Surgery

Status

Published

Forskningsgrupp

  • Clinical Microbiology, Malmö
  • Surgery

ISBN/ISSN/Övrigt

  • ISSN: 1532-2777